Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TransMedics (TMDX) Debt to Equity (2018 - 2025)

TransMedics has reported Debt to Equity over the past 8 years, most recently at $0.13 for Q4 2025.

  • Quarterly results put Debt to Equity at $0.13 for Q4 2025, down 51.5% from a year ago — trailing twelve months through Dec 2025 was $0.13 (down 51.5% YoY), and the annual figure for FY2025 was $0.13, down 51.5%.
  • Debt to Equity for Q4 2025 was $0.13 at TransMedics, down from $0.17 in the prior quarter.
  • Over the last five years, Debt to Equity for TMDX hit a ceiling of $0.7 in Q2 2022 and a floor of $0.13 in Q4 2025.
  • Median Debt to Equity over the past 5 years was $0.33 (2021), compared with a mean of $0.36.
  • Biggest five-year swings in Debt to Equity: surged 77.65% in 2022 and later crashed 51.5% in 2025.
  • TransMedics' Debt to Equity stood at $0.52 in 2021, then tumbled by 39.61% to $0.31 in 2022, then surged by 37.42% to $0.43 in 2023, then crashed by 39.67% to $0.26 in 2024, then crashed by 51.5% to $0.13 in 2025.
  • The last three reported values for Debt to Equity were $0.13 (Q4 2025), $0.17 (Q3 2025), and $0.19 (Q2 2025) per Business Quant data.